These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2045853)

  • 1. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.
    Hayes DF; Mesa-Tejada R; Papsidero LD; Croghan GA; Korzun AH; Norton L; Wood W; Strauchen JA; Grimes M; Weiss RB
    J Clin Oncol; 1991 Jul; 9(7):1113-23. PubMed ID: 2045853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a family of high molecular weight tumor-associated glycoproteins.
    Abe M; Kufe DW
    J Immunol; 1987 Jul; 139(1):257-61. PubMed ID: 2438351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
    Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.
    Hayes DF; Sekine H; Ohno T; Abe M; Keefe K; Kufe DW
    J Clin Invest; 1985 May; 75(5):1671-8. PubMed ID: 3889057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.
    Lundy J; Thor A; Maenza R; Schlom J; Forouhar F; Testa M; Kufe D
    Breast Cancer Res Treat; 1985; 5(3):269-76. PubMed ID: 2992647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells.
    Abe M; Kufe D
    J Cell Physiol; 1986 Jan; 126(1):126-32. PubMed ID: 2418036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
    Sekine H; Ohno T; Kufe DW
    J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptor.
    Damstrup L; Andersen J; Kufe DW; Hayes DF; Poulsen HS
    Ann Oncol; 1992 Jan; 3(1):71-7. PubMed ID: 1606073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
    Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
    Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.
    Perey L; Hayes DF; Maimonis P; Abe M; O'Hara C; Kufe DW
    Cancer Res; 1992 May; 52(9):2563-8. PubMed ID: 1373671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
    Kufe D; Inghirami G; Abe M; Hayes D; Justi-Wheeler H; Schlom J
    Hybridoma; 1984; 3(3):223-32. PubMed ID: 6094338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor-associated antigens detected by monoclonal antibodies against the polypeptide core of mucin--comparison of antigen MUSE11 with CA15-3.
    Hinoda Y; Kakiuchi H; Nakagawa N; Ohe Y; Sugiyama T; Tsujisaki M; Imai K; Yachi A
    Gastroenterol Jpn; 1992 Jun; 27(3):390-5. PubMed ID: 1378032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope.
    Perey L; Hayes DF; Kufe D
    Cancer Res; 1992 Nov; 52(22):6365-70. PubMed ID: 1384960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.